JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 3465
  • +85+2.51%
20min DelayNot Open Dec 19 15:30 JST
173.68BMarket Cap20.93P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Thomas Eastling
  • Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
Ondeck
7360
1338 +24.47%
Fujita
3370
272 +23.64%
Business Coach
9562
1663 +22.01%
Beenos
3328
4070 +20.77%
Livero
9245
1950 +18.90%

See the daily top gainer.